General Psychiatry is a leading open-access journal published by BMJ PUBLISHING GROUP, dedicated to advancing the field of psychiatry and mental health. With an impressive impact factor and ranked in the Q1 category across various related disciplines—including Psychiatry and Mental Health, as well as Clinical Neurology—this journal offers a vital platform for researchers and practitioners in the field to disseminate high-quality studies and insights. The journal has been open access since 2018, ensuring that the latest research is freely available to a global audience, thus fostering greater collaboration and innovation. With a focus on significant developments and emerging trends, General Psychiatry serves as an essential resource for professionals keen on improving mental health practices and understanding neurological aspects of mental disorders. The journal is based in the United Kingdom, reflecting a commitment to global health discussions and initiatives in psychiatry.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

PSYCHOANALYTIC PSYCHOLOGY is a distinguished journal published by the Educational Publishing Foundation of the American Psychological Association, specifically tailored to the field of Clinical Psychology. With an ISSN of 0736-9735 and an E-ISSN of 1939-1331, this journal has been a pivotal platform for scholarly discourse since its inception in 1984 and will continue to serve the academic community through 2024. While the journal currently operates under traditional access options, it maintains a reputable presence in the field, reflected by its ranking in the Q3 category for Clinical Psychology as of 2023, and a Scopus percentile that places it in the 41st percentile among its peers. Aimed at researchers, professionals, and students alike, PSYCHOANALYTIC PSYCHOLOGY is committed to advancing psychoanalytic practice and education through the dissemination of rigorous research findings, theoretical discussions, and innovative clinical practices, solidifying its importance in the continuous evolution of psychological science.

British Journal of Psychiatry, published by Cambridge University Press, stands as a pivotal resource in the realm of mental health and psychiatry. With an impressive impact reflected in its Q1 classifications in both Medicine (miscellaneous) and Psychiatry and Mental Health, this esteemed journal ranks 23rd out of 567 in its field according to Scopus, achieving an exceptional 96th percentile. Since its inception in 1963, the journal has continued to push the boundaries of research and discourse, serving as a platform for groundbreaking studies that enhance our understanding of psychiatric conditions and promote effective therapeutic strategies. Though it does not operate with an open-access model, the British Journal of Psychiatry remains an essential publication for researchers, clinicians, and students alike, offering in-depth insights and innovative findings that are crucial for navigating the complexities of mental health.

ACTA PSYCHIATRICA SCANDINAVICA is a leading journal in the field of Psychiatry and Mental Health, published by Wiley since its inception in 1926. With a strong commitment to advancing psychiatric research, this esteemed journal boasts an impressive impact factor and ranks within the top 7% of its category, reflecting its influence and relevance in the field. Operating without an Open Access model, the journal serves as a vital resource for professionals, researchers, and students keen on accessing high-quality, peer-reviewed studies focused on mental health issues. The scope of ACTA PSYCHIATRICA SCANDINAVICA spans a broad spectrum of psychiatric topics, providing a platform for groundbreaking research and clinical practice insights. Based in the United Kingdom and featuring contributions from experts worldwide, the journal continues to shape the future of psychiatric research through its rigorous publication standards and commitment to scholarly excellence.

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

Welcome to the British Journal of Clinical Psychology, a leading publication in the field of psychology, particularly recognized for its contributions to clinical practice and research since its inception. Published by Wiley, the journal boasts an impressive impact with a Q1 ranking in both Clinical Psychology and Medicine (Miscellaneous) categories as of 2023, evidenced by its placement at rank #65 out of 311 in Scopus for Clinical Psychology, reflecting its impactful and high-quality contributions in the domain. With a history stretching back to 1962 and ongoing publication through 2024, the journal provides a rigorous platform for researchers, professionals, and students to disseminate and engage with innovative studies, methodologies, and clinical insights. Although it does not currently operate under an Open Access model, the journal’s commitment to enhancing knowledge and practice in clinical psychology makes it an indispensable resource for anyone involved in psychological research and practice.

Welcome to the Spanish Journal of Psychiatry and Mental Health, a leading platform for innovative research and discourse in the fields of psychiatry and mental health. Published by ELSEVIER ESPANA SLU, this peer-reviewed journal serves as a critical resource for clinicians, researchers, and students dedicated to advancing understanding and treatment of mental health disorders. With a commendable ranking of #54 out of 567 in the Psychiatry and Mental Health category according to Scopus, it proudly positions itself in the 90th percentile, reinforcing its significance within the academic community. As an open-access journal, it aims to disseminate high-quality research to a global audience, promoting collaboration and knowledge sharing among mental health professionals. The journal's dynamic publication schedule, covering Converged Years from 2023 to 2024, ensures that it remains at the forefront of mental health scholarship. We invite you to explore the latest findings, engage with thought-provoking articles, and contribute to the ongoing dialogue in this vital discipline.

PSYCHOPATHOLOGY, published by KARGER, is a prestigious academic journal that has been a cornerstone in the fields of clinical psychology and psychiatry since its inception in 1968. With a robust impact factor and a commendable ranking within the upper quartiles (Q1) of its categories for 2023, the journal is recognized for its rigorous peer-reviewed articles that contribute significantly to the understanding and treatment of mental health disorders. Hailing from the beautiful country of Switzerland, this journal not only fosters innovative research but also encourages interdisciplinary collaboration among scholars, practitioners, and students alike. Although currently not an Open Access journal, it continues to provide valuable insights, enhancing the understanding of psychopathological phenomena and promoting better clinical practices. With a commitment to excellence, PSYCHOPATHOLOGY aims to disseminate crucial findings and innovative methodologies that shape the future of mental health research.

Psychiatry and Behavioral Sciences is an esteemed journal dedicated to advancing the understanding of mental health and behavioral disorders. Published by YERKURE TANITIM & YAYINCILIK HIZMETLERI A S, this journal provides a platform for groundbreaking research and scholarly articles in the field of psychiatry, psychology, and related disciplines. With an E-ISSN of 2636-834X, Psychiatry and Behavioral Sciences aims to disseminate knowledge that contributes to the effectiveness of treatments, the development of novel therapeutic practices, and the promotion of mental well-being. Although currently not an Open Access journal, it retains a commitment to reaching a wide audience through institutional subscriptions and partnerships. Scholars, practitioners, and students alike will find valuable insights and evidence-based research within its pages, making it an essential resource for anyone involved in the study or practice of mental health.